Accuron Technologies plans to further develop its suite of medical devices outsourcing services through its recent acquisition of a majority stake in Aurum Healthcare , a provider of sterilisation services for medical devices and instruments.
"Nantong Jinghua Pharma will become a 78.3% stakeholder in Jiangsu Kingsley Pharmaceuticals."
According to the agreement, Accuron Technologies will place Aurum Healthcare under its Advanced Materials Technologies (AMT ) business in order to increase AMT ‘s manufacturing footprint.
Nantong Jinghua Pharma, a Chinese traditional pharma products manufacturer, plans to acquire an additional 29.73% stake in Jiangsu Kingsley Pharmaceuticals.
Following the transaction, Nantong Jinghua Pharma will become a 78.3% stakeholder in Jiangsu Kingsley Pharmaceuticals.
Related Articles
Related Companies
